63.85
Soleno Therapeutics Inc Aktie (SLNO) Neueste Nachrichten
Soleno Therapeutics Achieves Profitability with VYKAT XR Launch - TipRanks
Earnings call transcript: Soleno Therapeutics Q3 2025 earnings beat expectations - Investing.com
Soleno Therapeutics tumbles despite Q3 earnings, revenue beat By Investing.com - Investing.com UK
Soleno Therapeutics Turns A Profit Thanks To VYKAT XR - Finimize
Soleno Therapeutics tumbles despite Q3 earnings, revenue beat - Investing.com
SOLENO THERAPEUTICS INC SEC 10-Q Report - TradingView
Earnings Flash (SLNO) Soleno Therapeutics, Inc. Reports Q3 Revenue $66.0M, vs. FactSet Est of $48.1M - MarketScreener
Soleno Therapeutics Reports Third Quarter 2025 Financial Results and Provides Update on U.S. Launch of VYKAT(TM) XR - The Manila Times
Full technical analysis of Soleno Therapeutics Inc. stock2025 Macro Impact & Verified Momentum Stock Ideas - newser.com
Can Soleno Therapeutics Inc. stock outperform in 2025 bull marketWeekly Investment Report & Weekly Stock Performance Updates - newser.com
Real time social sentiment graph for Soleno Therapeutics Inc.July 2025 Breakouts & Free Reliable Trade Execution Plans - newser.com
Will Soleno Therapeutics Inc. (6XC) stock outperform small cap peersJuly 2025 Macro Moves & Weekly High Return Stock Forecasts - newser.com
Is Soleno Therapeutics Inc. stock a smart buy before Fed meetingAnalyst Upgrade & Scalable Portfolio Growth Methods - newser.com
Is Soleno Therapeutics Inc. (6XC) stock good for long term investingAnalyst Upgrade & Growth Oriented Trading Recommendations - newser.com
Published on: 2025-11-04 00:54:52 - newser.com
Strategies to average down on Soleno Therapeutics Inc.Quarterly Portfolio Summary & Growth Oriented Trading Recommendations - newser.com
Soleno Therapeutics Q3 Earnings Preview - MSN
Hot Picks: Investor highlights small-cap opportunities in energy, industrial tech and biotech - BNN Bloomberg
Has Soleno Therapeutics Inc. formed a bullish divergence2025 Top Decliners & Reliable Entry Point Alerts - newser.com
Published on: 2025-11-03 08:08:49 - newser.com
Soleno Therapeutics Inc (SLNO) Q3 2025 Earnings Report Preview: What To Look For - GuruFocus
Will Soleno Therapeutics Inc. stock reach Wall Street targetsTrade Risk Assessment & Consistent Income Trade Recommendations - newser.com
What data driven models say about Soleno Therapeutics Inc.’s future2025 Trade Ideas & Fast Entry Momentum Trade Alerts - newser.com
Will Soleno Therapeutics Inc. outperform the marketJuly 2025 News Drivers & Expert-Curated Trade Recommendations - newser.com
How moving averages guide Soleno Therapeutics Inc. tradingAnalyst Downgrade & Long-Term Safe Investment Plans - newser.com
Order flow analysis tools used on Soleno Therapeutics Inc.2025 Earnings Surprises & Entry Point Strategy Guides - newser.com
What hedge fund activity signals for Soleno Therapeutics Inc. stock2025 Trade Ideas & Real-Time Volume Analysis Alerts - newser.com
Moody Aldrich Partners LLC Has $3.48 Million Position in Soleno Therapeutics, Inc. $SLNO - MarketBeat
How Soleno Therapeutics Inc. stock benefits from strong dollarJuly 2025 Intraday Action & AI Forecasted Entry/Exit Points - newser.com
Soleno Therapeutics, Inc. $SLNO Shares Acquired by Emerald Mutual Fund Advisers Trust - MarketBeat
Is Soleno Therapeutics Inc. a candidate for recovery play2025 Market Sentiment & Consistent Growth Equity Picks - newser.com
Is Soleno Therapeutics Inc. stock a bargain at current levelsEarnings Overview Summary & Real-Time Chart Pattern Alerts - newser.com
Will Soleno Therapeutics Inc. stock benefit from upcoming earnings reportsMarket Risk Summary & Daily Market Momentum Tracking - newser.com
Soleno Therapeutics (SLNO): Assessing Valuation Following Securities Probe and Short-Seller Safety Allegations - Sahm
Will Soleno Therapeutics Inc. stock outperform tech sector in 2025Portfolio Return Report & Safe Entry Zone Identification - newser.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):